Compare PROF & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PROF | ARQQ |
|---|---|---|
| Founded | N/A | 2017 |
| Country | Canada | United Kingdom |
| Employees | N/A | 91 |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.8M | 289.8M |
| IPO Year | 2017 | N/A |
| Metric | PROF | ARQQ |
|---|---|---|
| Price | $7.44 | $17.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $12.00 | ★ $60.00 |
| AVG Volume (30 Days) | 118.2K | ★ 458.2K |
| Earning Date | 05-07-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.89 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $16,098,000.00 | N/A |
| Revenue This Year | $92.40 | $381.13 |
| Revenue Next Year | $64.10 | $212.00 |
| P/E Ratio | $38.32 | ★ N/A |
| Revenue Growth | ★ 50.73 | N/A |
| 52 Week Low | $3.92 | $11.52 |
| 52 Week High | $8.95 | $62.00 |
| Indicator | PROF | ARQQ |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 46.75 |
| Support Level | $7.00 | $15.54 |
| Resistance Level | $7.93 | $18.02 |
| Average True Range (ATR) | 0.38 | 1.76 |
| MACD | 0.01 | -0.18 |
| Stochastic Oscillator | 40.26 | 51.83 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.